Fibrocyte-like cells mediate acquired resistance to anti-angiogenic therapy with bevacizumab. (Q36392523)

From Wikidata
Jump to navigation Jump to search
scientific article published on 4 December 2015
edit
Language Label Description Also known as
English
Fibrocyte-like cells mediate acquired resistance to anti-angiogenic therapy with bevacizumab.
scientific article published on 4 December 2015

    Statements

    Fibrocyte-like cells mediate acquired resistance to anti-angiogenic therapy with bevacizumab (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit